The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

The spotlight is on earnings season after a surprise jobs report called into question when the next interest-rate cut will ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

Starboard has also approached Ian Read, a former Pfizer CEO, and Frank D'Amelio, who served as CFO until 2021, and both have ...

Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

Pfizer (PFE) shares were up 4% Monday morning in the wake of reports that activist investor Starboard Value had taken a ...

Pharmaceutical giant Pfizer (PFE) is seeing stock gains in Monday's pre-market trading after activist investor Starboard ...

Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance.